Massachusetts Medicaid Case Against Mylan to Continue

A federal judge in Massachusetts has refused to dismiss a case against Mylan Laboratories in which the company is accused of overcharging the state Medicaid system for certain generic drugs. Mylan was accused of overcharging for its generic versions of Biovail’s anti-anxiety drug Ativan (lorazepam), Novartis’ schizophrenia treatment Clozaril (clozapine) and Parke-Davis’ anti-seizure drug Dilantin Kapseals (phenytoin sodium), according to court documents.
Generic Line